A61K 33 - Medicinal preparations containing inorganic active ingredients

Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
10/2002
10/31/2002	WO2002085386A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue
10/31/2002	WO2002085385A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa
10/31/2002	WO2002085384A2 Lubricious coatings for substrates
10/31/2002	WO2002085348A1 Use of rare earth compounds for the prevention of kidney stone disease
10/31/2002	WO2002085299A2 Therapeutic treatments using the direct application of antimicrobial metal compositions
10/31/2002	WO2002085113A1 Controlled release particles
10/31/2002	WO2002067879A3 Material composition and oral galenic form against hair loss and brittle nails
10/31/2002	WO2002067853A3 A combination and method of treatment of hiv and viral diseases, vascular disease and cancer utilizing a cox-2 inhibitor and cystine
10/31/2002	WO2002051428A8 Sympathetic-activating perfume composition
10/31/2002	WO2001087348A3 Multifunctional nanodevice platform
10/31/2002	US20020161042 Nitric oxide donor composition and method for treatment of anal disorders
10/31/2002	US20020161020 Stablization of quinapril using magnesium oxide
10/31/2002	US20020160056 Delivering source of iontophoretically deliverable lithium to patient through skin via dermal patch; treatment of acute mania or bipolar disorder
10/31/2002	US20020160055 Methods for treating human immunodeficiency virus infections with gallium compositions
10/31/2002	US20020160053 Solution for promoting growth of tissue cells at wound sites and production process therefor
10/31/2002	CA2445740A1 Use of metals to treat inflammatory skin conditions
10/31/2002	CA2445734A1 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue
10/31/2002	CA2445729A1 Use of metals to treat mucosal membranes
10/31/2002	CA2444219A1 Antiangiogenic combination therapy for the treatment of cancer
10/31/2002	CA2443587A1 Therapeutic treatments using the direct application of antimicrobial metal compositions
10/31/2002	CA2443518A1 Controlled release particles
10/30/2002	EP1252824A2 Method for improving bone mineralization
10/30/2002	EP1252175A1 Antisense modulation of survivin expression
10/30/2002	EP1251845A1 Purifying polyoxyethylated castor oils with activated charcoal and pharmaceutical formulations thereof
10/30/2002	EP1251840A2 Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor
10/30/2002	EP1251824A2 Methods of using a beverage composition for treating dental erosion
10/30/2002	EP1251750A1 Improved pediatric formula and methods for providing nutrition and improving tolerance
10/30/2002	EP1056439B1 Oral care compositions comprising chlorite
10/30/2002	CN1377269A Vitronectin receptor antagonists
10/30/2002	CN1377266A Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion
10/30/2002	CN1377252A Composition for restoring defects in calcified tissues
10/30/2002	CN1376495A Chinese medicine for treating diabetes and its complication
10/30/2002	CN1376489A Chinese medicine for treating ulcerative colitis and its preparing process
10/30/2002	CN1376486A Detoxicating and skin-growing powder for treating burn
10/30/2002	CN1376470A Ointment for dispelling wind and relieving rigidity of muscles and joints and its preparing process
10/30/2002	CN1093417C Medicine for treating hair pore shrinkage and its praparing process
10/30/2002	CN1093413C Traditional Chinese medicine for treating asthma
10/30/2002	CN1093400C Oral preparation with dimethoate detoxicating
10/29/2002	US6472507 Carrier based drug delivery system
10/29/2002	US6472420 Method for treating a patient with neoplasia by treatment with a paclitaxel derivative
10/29/2002	US6471978 Localized use of nitric oxide-adducts to prevent internal tissue damage
10/29/2002	US6471972 Cosmetic treatment method for fighting against skin ageing effects
10/29/2002	US6471968 Multifunctional nanodevice platform
10/29/2002	US6471946 Oral composition
10/29/2002	CA2283314C Ointment for the treatment of burns and of other skin diseases
10/29/2002	CA2263455C Liposomes containing a cisplatin compound
10/29/2002	CA2138683C Semi-paste oral preparations
10/24/2002	WO2002083926A2 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
10/24/2002	WO2002083124A1 A composition and method of sustaining chemotherapeutic effect while reducing dose of chemotherapeutic agent using cox-2 inhibitor and statin
10/24/2002	WO2002083116A1 Methods of treating prion disease in mammals comprising administering a chaotropic agent such as guanidine, urea or potassium iodide
10/24/2002	WO2002083104A1 An effervescent solid composition of matter
10/24/2002	WO2002024610A3 Method for producing an antineoplastic
10/24/2002	WO2001068135A9 Compositions and methods for affecting osteogenesis
10/24/2002	US20020155997 Biologically active material isolated from non-pathogenic bacteria, such as Enterobacteriaceae
10/24/2002	US20020155527 Nucleotide sequences coding membrane protein for use in the treatment of tumors
10/24/2002	US20020155174 Acidified nitrite as an antimicrobial agent
10/24/2002	US20020155171 Mixtures of peptide, minerals and vitamins
10/24/2002	US20020155168 Use of rare earth compounds for the prevention of kidney stone disease
10/24/2002	US20020155166 For therapy of heart, lung, liver, spleen, brain, skin and kidney diseases and other conditions and disease states including, for example, asthma, emphysema, bronchitis, adult respiratory distress syndrome, sepsis, cystic fibrosis
10/24/2002	US20020155165 Method for treating renal disease, and pharmaceutical composition for treating renal disease
10/24/2002	US20020155164 System and method for the prevention of infections in human patients using nitric oxide
10/24/2002	US20020155163 Integrated multi-vitamin and mineral combination
10/24/2002	US20020155149 Iodophor compositions
10/24/2002	US20020155103 Activated charcoal based composition and method for reducing hangover symptomps associated with the consumption of alcohol containing beverages
10/24/2002	US20020155098 Methods for treating the inflammatory component of a brain disorder
10/24/2002	CA2444548A1 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
10/24/2002	CA2443900A1 Methods of treating prion disease in mammals comprising administering a chaotropic agent such as guanidine, urea or potassium iodide
10/24/2002	CA2443471A1 An effervescent solid composition of matter
10/23/2002	EP1250142A1 Multivalent electron active compositions and methods of making and using same
10/23/2002	EP1250135A1 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
10/23/2002	EP1250116A1 Pharmaceutical and cosmetic carrier or composition for topical application
10/23/2002	EP0626845B1 Improved amino acid solutions for treatment of peritoneal dialysis patients
10/23/2002	CN1376036A Metal-containing compositions, preparations and uses
10/23/2002	CN1375313A Recipe and prepn. process of medicine for treating burns and scalds
10/23/2002	CN1375303A Ointment for dredging meridian passage and expelling wind-evil
10/23/2002	CN1375294A Arsenic trioxide powder for injection
10/23/2002	CN1092971C Chinese medicine for treating rheumatism
10/23/2002	CN1092967C Powdered medicine for treating simple baby diarrhea
10/23/2002	CN1092963C Antiacid compositions and pharmaceutical compositions
10/22/2002	US6469058 For the treatment of nonsmall cell lung cancer
10/22/2002	US6468962 Nutritional intervention composition for enhancing and extending satiety
10/22/2002	US6468504 Composition comprising methylphenidate and another drug
10/22/2002	CA2216437C Pharmaceutical composition containing selected lanthanum carbonate hydrates
10/22/2002	CA2136614C Nitrous oxide containing dermatological composition
10/22/2002	CA2106954C Dry starch-iodine pharmaceutical formulations
10/17/2002	WO2002080955A1 Stimulation of osteogenesis using rank ligand fusion proteins
10/17/2002	WO2002080945A2 Methods for treating the inflammatory component of a brain disorder
10/17/2002	WO2002080943A1 Zinc ionophores as anti-stress agents
10/17/2002	WO2002080942A1 Pharmaceutical composition comprising copper, salicyclic acid, vitamin c and zinc for use in treatment of different diseases such as bacterial or viral infection
10/17/2002	WO2002080941A1 Compositions for preparing external carbon dioxide agents
10/17/2002	WO2002080940A2 Pharmacologically active strong acid solutions
10/17/2002	WO2002080922A1 Method and composition for topical treatment of viral lesions
10/17/2002	WO2002080889A2 A combination dosage of a cyclooxygenase (cox) inhibitor, a vitamin d3 including analogues and metabolites thereof and/or calcium for prevention of epithelial cancer
10/17/2002	WO2002080854A2 Compositions and methods for the prevention and treatment of human prostate cancer
10/17/2002	WO2002080849A2 Chemotherapeutic induction of egr-1 promoter activity
10/17/2002	WO2002080754A2 Methods for using annexin for detecting cell death in vivo and treating associated conditions
10/17/2002	WO2002062260A3 Improved ophthalmic and contact lens solutions containing forms of vitamin b
10/17/2002	WO2002049693A3 Sterile low bicarbonate dialysis concentrate solutions
10/17/2002	WO2002047493A3 Health promoting compositions
10/17/2002	WO2001049279A3 Use of steroidal alkaloids to reverse multidrug resistance

1 ... 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 ... 563